MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Drug Delivery
CNS Therapeutics
Attachments
CNS Therapeutics
Parents
*Architects: Drug Delivery
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars)
*Industry: Minnesota
Companies: Acquired_(M&A)
Finance & Acquisitions: Covidien
Children
Amount: $3M Round: Venture Capital Past Investor(s) InterWest Partners, Thomas McNerney and Partners
CNS President John Foster
CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, CNS Therapeutics
CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system.
CNS Therapeutics sold to Covidien for $100M - Minneapolis (2012)
Founded 2007
Previous investors InterWest Partners and Thomas McNerney Partners led this round
The company raised $6 million 2008
The early-stage pharmaceutical company CNS Therapeutics has raised $7 million in a Series B (2009)